A.D.A.M. "SmartCareV1.2" Receives Meaningful Use

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
A.D.A.M. "SmartCareV1.2" Receives Meaningful Use Certification With eClinicalWorks V10.0

ATLANTA, July 8, 2014 (GLOBE NEWSWIRE) -- Ebix, Inc. (Nasdaq: EBIX ), a leading international supplier of On-Demand software and E-commerce services to the insurance industry, today announced that the Company's A.D.A.M. Health Content Exchange, including A.D.A.M.'s SmartCare patient education program, has been officially certified by the Certification Commission for Health Information Technology (CCHIT ® ) within eClinicalWorks V10 Electronic Health Records (EHR) solution. EHR technology certified in CCHIT's ONC HIT Certification Program meets U.S. Department of Health and Human Services requirements supporting meaningful use.

The Patient Protection and Affordable Care Act (PPACA), also known as the Affordable Care Act (ACA), is a United States federal statute signed into law on March 23, 2010. A new electronic health record mandate was added to PPACA to ensure the protection of privacy, while streamlining the medical record system. This electronic records mandate is set to take effect in 2014. Currently the ACA requires that clinicians provide patients with "patient-specific education" with the inclusion of this capability being a must for an EHR vendor to be certified by CCHIT.

Through its partnership with eClinicalWorks, A.D.A.M.'s SmartCare™ will be available to all physicians using eClinicalWorks, to help them provide patients with detailed and robust patient education material. Bolstered by A.D.A.M.'s award-winning images and evidence-based content, SmartCare gives clinicians instant access to thousands of clinically-accurate patient education articles for every stage of the continuum – before, during and after care. The articles are written by leading medical experts and reviewed to meet national health literacy guidelines, complete with award-winning A.D.A.M. images. SmartCare also meets The Joint Commission standards for plain language and available information, is HL7/infobutton-friendly, and navigation is enabled via keyword, ICD-9, ICD-10, SnoMed, Loinc, RxNorm, NDC and/or CPT codes to access articles.

Vice President of A.D.A.M. Soula Chronopoulos said, "We have created the next generation of Patient Education and this CCHIT certification will showcase our interoperability along with our numerous methodologies to deliver it to all aspects of the healthcare industry."

As the healthcare industry continues to implement the Affordable Care Act, EHRs have become the cornerstone in managing a patient's health, not just documenting it. To that end, A.D.A.M. has created robust, interactive patient content that helps the clinician manage and coordinate the patient's care and helps the patient understand how to better comply with their own care. A.D.A.M.'s comprehensive content coupled with its contemporary technology and easy-to-use interface has proven to be a leader in assisting clinicians in educating patients on complex medical subjects, while providing them with a better understanding of how and what they should do to increase positive outcomes.

With its team of in-house educators, medical writers, editors, programmers, and medical illustrators, A.D.A.M. develops exciting interactive solutions for educators, health professionals, pharmaceutical representatives, medical students, search engines, media, hospitals, insurance companies, patients and consumers etc. on an on-Demand basis.

About eClinicalWorks

eClinicalWorks ® is a privately-held leader in ambulatory healthcare IT solutions. With organizations across all 50 states relying on its solutions, customers include ACOs, physician practices, out-patient departments of hospitals, health centers, departments of health and convenient care clinics.  Ten eClinicalWorks customers  have received the prestigious HIMSS Davies Awards during the past six years, honoring excellence in electronic health record implementation. The company is the second largest vendor in the country for e-prescribing. Based in Westborough, Mass., eClinicalWorks has additional offices in New York City, Chicago, California and Georgia. For more information, please visit healow.com , eclinicalworks.com ,  Facebook ,  Twitter  or call 866-888-6929. 

About Ebix, Inc. and A.D.A.M.

A.D.A.M. is a business unit of Ebix focused on providing innovative multimedia health content trusted by best-in-class websites, consumer health portals, healthcare, biomedical, medical device, pharmaceutical, and education organizations.

A leading international supplier of On-Demand software and E-commerce services to the insurance industry, Ebix, Inc., (Nasdaq: EBIX ) provides end-to-end solutions ranging from infrastructure exchanges, carrier systems, agency systems and BPO services to custom software development for all entities involved in the insurance industry.

With 30+ offices across Brazil, Singapore, Australia, the U.S., New Zealand, India and Canada, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance while conducting in excess of $100 billion in insurance premiums on its platforms. Through its various SaaS-based software platforms, Ebix employs hundreds of insurance and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company's website at  www.ebix.com .

Investors Steven Barlow, Vice President - Investor Relations 678-281-2043 or Aaron Tikkoo 678-281-2027 or Marketing Kristin Blake Harper, Marketing 404-418-9892 or

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 403

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 54

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 512

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

DoubleLine Income Solutions Fund Announces Upcoming Dividend

Updated Category News Views 125

DoubleLine Income Solutions Fund Announces Distribution The DoubleLine Income Solutions Fund, symbolized as DSL on the New York Stock Exchange, has recently declared a distribution of $0.11 per share for the upcoming month. This announcement is significant for investors looking to maximize their income through dividend investments. Details of the Distribution The Board of...

Continue Reading
EQT Corporation Extends Exchange Offers and Consent Solicitations

Updated Category News Views 161

EQT Corporation Extends Exchange Offers and Consent Solicitations EQT Corporation (NYSE: EQT) recently revealed an important update regarding its exchange offers and consent solicitations. This announcement reflects the company’s commitment to providing clarity and opportunities for its stakeholders. The expiration date for these offers has been extended, showcasing...

Continue Reading
Middlefield U.S. Equity Dividend ETF Distributes Key Updates

Updated Category News Views 187

Recent Distributions from Middlefield U.S. Equity Dividend ETF Middlefield U.S. Equity Dividend ETF (TSX: MUSA) has exciting news regarding its distributions for unitholders. These distributions for the fourth quarter promise to benefit investors looking for reliable income through dividends. The Fund has announced a structured schedule that highlights key dates and...

Continue Reading
Bankruptcy Filing Announced for RUAB 'Alinita': Insights

Updated Category News Views 282

Bankruptcy Filing Announced for RUAB 'Alinita' The Panev?žys Regional Court, in a decisive ruling, has transitioned RUAB 'Alinita' into bankruptcy proceedings. This move follows the termination of its restructuring efforts which commenced on a specific date in the recent past. The company, part of the PST Group AB corporate structure, now finds itself looking toward a...

Continue Reading
Gold Prices Remain Strong Amid Fed Policy Concerns

Updated Category News Views 218

Gold Prices Maintain Strength as Market Eyes Federal Reserve Gold continues to command attention in the markets, currently trading close to $2,370. This performance is particularly notable as it stands just below a two-week high, attracting buyers due to its perceived safe-haven quality amid increasing concerns surrounding Federal Reserve's independence. Events...

Continue Reading